Royal Bank of Canada’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
15,615
-63,618
| -80% | -$717K | ﹤0.01% | 4915 |
|
|
2025
Q1 | $362K | Sell |
79,233
-612
| -0.8% | -$2.8K | ﹤0.01% | 3921 |
|
|
2024
Q4 | $450K | Buy |
79,845
+43,331
| +119% | +$244K | ﹤0.01% | 3724 |
|
|
2024
Q3 | $176K | Buy |
36,514
+26,024
| +248% | +$125K | ﹤0.01% | 4483 |
|
|
2024
Q2 | $51K | Sell |
10,490
-7,161
| -41% | -$34.8K | ﹤0.01% | 5266 |
|
|
2024
Q1 | $235K | Buy |
17,651
+4,200
| +31% | +$55.9K | ﹤0.01% | 4133 |
|
|
2023
Q4 | $187K | Sell |
13,451
-6,429
| -32% | -$89.4K | ﹤0.01% | 4639 |
|
|
2023
Q3 | $263K | Buy |
19,880
+2,801
| +16% | +$37.1K | ﹤0.01% | 4088 |
|
|
2023
Q2 | $320K | Buy |
17,079
+5,856
| +52% | +$110K | ﹤0.01% | 3920 |
|
|
2023
Q1 | $161K | Sell |
11,223
-1,300
| -10% | -$18.6K | ﹤0.01% | 4431 |
|
|
2022
Q4 | $243K | Buy |
12,523
+5,237
| +72% | +$102K | ﹤0.01% | 4261 |
|
|
2022
Q3 | $250K | Buy |
7,286
+6,155
| +544% | +$211K | ﹤0.01% | 4113 |
|
|
2022
Q2 | $17K | Sell |
1,131
-1,440
| -56% | -$21.6K | ﹤0.01% | 5718 |
|
|
2022
Q1 | $58K | Sell |
2,571
-4,455
| -63% | -$101K | ﹤0.01% | 5515 |
|
|
2021
Q4 | $260K | Sell |
7,026
-1,834
| -21% | -$67.9K | ﹤0.01% | 4562 |
|
|
2021
Q3 | $416K | Buy |
8,860
+1,760
| +25% | +$82.6K | ﹤0.01% | 4025 |
|
|
2021
Q2 | $428K | Buy |
+7,100
| New | +$428K | ﹤0.01% | 3981 |
|